Rheumatoid arthritis is a crippling condition affecting 1.3 million people. To date, the standard of care has been to head ...

New developments in regenerative medicine are providing alternative solutions that aim to address the underlying issues of ...

This systematic review of real-world observational studies demonstrated the effectiveness of Janus kinase (JAK) inhibitors in ...

Learn about rheumatoid vasculitis, neutrophilic dermatoses, and other rheumatoid arthritis rashes, their symptoms, and when ...

The second type is rheumatoid arthritis ... board-certified and trained to diagnose and focus on non-surgical treatments of arthritis and related diseases. Dr. Kelsey Pasch of The Baton Rouge ...

A new clinical study highlighted the potential of ivarmacitinib, a selective Janus kinase (JAK) 1 inhibitor, as an effective ...

Early treatment escalation to biologic or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) following methotrexate (MTX) failure in new-onset rheumatoid arthritis (RA) does not ...

Cerebras Systems has teamed with Mayo Clinic to create an AI genomic foundation model that predicts the best medical treatments.

Artificial intelligence (AI) can significantly aid in early detection of autoimmune diseases, like rheumatoid arthritis and ...